Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G.F. Koob

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Behavioural Pharmacology|June 1, 1995
Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the ratS.B. Caine, G.F. Koob
Behavioural Pharmacology|January 1, 1989
Spatial pattern analysis reveals similarities between amphetamine conditioned and unconditioned locomotionL.H. Gold, G.F. Koob, M.A. Geyer
Behavioural Pharmacology|December 1, 1991
Hypertonic saline mimics the effects of vasopressin and social recognition in ratsR-M. Bluthé, G.F. Koob, R. Dantzer
Behavioural Pharmacology|January 1, 1995
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawalS.C. Heinrichs, F. Menzaghi, G. Schulteis, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Behavioural Pharmacology|June 1, 1995
Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the ratS.B. Caine, G.F. Koob
Behavioural Pharmacology|January 1, 1989
Spatial pattern analysis reveals similarities between amphetamine conditioned and unconditioned locomotionL.H. Gold, G.F. Koob, M.A. Geyer
Behavioural Pharmacology|December 1, 1991
Hypertonic saline mimics the effects of vasopressin and social recognition in ratsR-M. Bluthé, G.F. Koob, R. Dantzer
Behavioural Pharmacology|January 1, 1995
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawalS.C. Heinrichs, F. Menzaghi, G. Schulteis, et al.
Pageof 1